Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]
Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic di…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation)
The ELEVATE trial evaluating remote evaluation for systemic lupus erythematosus, sponsored by DxTerity Diagnostics, has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Effect of Vitamin D Supplement on Disease Activity in SLE [NA]
Completed clinical trial evaluating whether Vitamin D3 (Cholecalciferol) supplementation affects disease activity in Systemic Lupus Erythema…
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity [NA]
A completed clinical trial investigating whether the renal resistive index can indicate lupus nephritis severity and systemic lupus activity…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies
This clinical trial update reports long-term outcomes in children and adolescents with antiphospholipid antibodies, with a focus on systemic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Fatigue in Systemic Lupus Erythematosus
Pamukkale University–sponsored clinical trial investigating fatigue in systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases [Phase 1]
Amgen reported completion of a Phase 1 study of MEDI7734 in Type I interferon-mediated autoimmune diseases, including dermatomyositis, polym…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus Study [NA]
This clinical trial update notes the completion of the Living Well with Lupus study, which evaluated a healthy lifestyle intervention in pat…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial [Phase 2]
Phase 2 multicenter randomized, placebo-controlled trial evaluating low-dose interleukin-2 for systemic lupus erythematosus has completed, r…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' Patients [NA]
Clinical trial update examining how an exercise program affects hand function, daily activities, and quality of life in patients with System…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis [Phase 2]
Phase 2 pediatric trial evaluating curcumin for active lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Immune Cell Subsets in SLE Patients Treated with Telitacicept [Phase 4]
Phase 4 clinical trial evaluating immune cell subsets in systemic lupus erythematosus patients treated with Telitacicept; the study is curre…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE) [Phase 1]
Phase 1 multiple ascending dose study of MHS552 in adults with systemic lupus erythematosus was terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) [Phase 2]
Phase 2 trial assessing the efficacy and safety of AMG 570 in active systemic lupus erythematosus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Progressive Resisted Exercise Plus Aerobic Exercise on Osteoporotic Systemic Lupus Erythmatosus [NA]
A completed clinical trial from Cairo University evaluating a combined progressive resisted exercise and aerobic program in individuals with…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study [Phase 2]
A Phase 2 open-label extension study of Daxdilimab (HZN-7734) for systemic lupus erythematosus was terminated; results were posted on 2024-0…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
This clinical trial update notes that the study evaluating gynecological follow-up in patients with autoimmune diseases and inflammatory rhe…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Bone Mineral Density in Patients With Childhood-onset Systemic Lupus Erythematous, in Relation to Disease Clinical Criteria
A clinical trial update regarding bone mineral density in patients with childhood-onset systemic lupus erythematosus, related to disease cri…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) [Phase 2]
Pfizer completed a Phase 2 dose-ranging study evaluating the efficacy and safety of PF-06700841 in systemic lupus erythematosus and posted t…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease [NA]
This clinical trial update reports a study of YTS109 cell injection for recurrent or refractory autoimmune diseases that is currently recrui…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Exercise and Arterial Stiffness in Systemic Lupus Erythematosus [NA]
This clinical trial examining the effect of exercise on arterial stiffness in systemic lupus erythematosus has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Effects of Nigella Sativa on T Cells and Cytokine Profile in Pediatric SLE Patients [NA]
A completed clinical trial assessing the immunomodulatory effects of Nigella Sativa on T cells and cytokine profiles in pediatric systemic l…
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects [Phase 1]
This Phase 1 trial evaluates the safety and pharmacokinetics of TQB3702 tablets in healthy adult subjects. The listed condition associated w…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: CCCR Lupus Patient Navigator Program [NA]
The CCCR Lupus Patient Navigator Program trial for systemic lupus erythematosus has completed and posted results in August 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus [Phase 1, Phase 2]
An open-label Phase 1/2 trial evaluating the JAK inhibitor tofacitinib for cutaneous lupus erythematosus and systemic lupus erythematosus in…